These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22322235)

  • 41. Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis.
    Kershisnik MM; Knisely AS; Sun CC; Andrews JM; Wittwer CT
    Hum Pathol; 1992 Sep; 23(9):1075-80. PubMed ID: 1325409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transient neonatal liver disease after maternal antenatal intravenous Ig infusions in gestational alloimmune liver disease associated with neonatal haemochromatosis.
    Baruteau J; Heissat S; Broué P; Collardeau-Frachon S; Bouvier R; Fabre M; Debiec H; Ronco P; Uzan M; Narcy P; Cordier MP; Lachaux A; Lamireau T; Elleau C; Filet JP; Mitanchez D; Dupuy MP; Salaün JF; Odent S; Davison J; Debray D; Guigonis V
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):629-35. PubMed ID: 25079484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
    Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
    Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin.
    Fletcher LM; Halliday JW; Powell LW
    J Gastroenterol Hepatol; 1999 Mar; 14(3):202-14. PubMed ID: 10197487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemochromatosis: genetics and pathophysiology.
    Beutler E
    Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
    Arnold J; Sangwaiya A; Bhatkal B; Arnold A
    Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Broadening the spectrum of neonatal hemochromatosis.
    Casas-Alba D; Clotet J; Inarejos EJ; Jou C; Fons C; Molera C
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):1024-1026. PubMed ID: 30058407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.
    Bardou-Jacquet E; Philip J; Lorho R; Ropert M; Latournerie M; Houssel-Debry P; Guyader D; Loréal O; Boudjema K; Brissot P
    Hepatology; 2014 Mar; 59(3):839-47. PubMed ID: 23775519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease.
    Schaefer B; Haschka D; Finkenstedt A; Petersen BS; Theurl I; Henninger B; Janecke AR; Wang CY; Lin HY; Veits L; Vogel W; Weiss G; Franke A; Zoller H
    Hum Mol Genet; 2015 Nov; 24(21):6254-63. PubMed ID: 26310624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
    Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
    J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iron metabolism: State of the art.
    Daher R; Karim Z
    Transfus Clin Biol; 2017 Sep; 24(3):115-119. PubMed ID: 28694024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Liver cirrhosis with siderosis. II].
    Abad Alonso JA
    Rev Clin Esp; 1970 Feb; 116(4):319-26. PubMed ID: 4922359
    [No Abstract]   [Full Text] [Related]  

  • 57. Neonatal haemochromatosis with reversible pituitary involvement.
    Indolfi G; Bèrczes R; Pelliccioli I; Bosisio M; Agostinis C; Resti M; Zambelli M; Lucianetti A; Colledan M; D'Antiga L
    Transpl Int; 2014 Aug; 27(8):e76-9. PubMed ID: 24725070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Liver cirrhosis with siderosis].
    Abad Alonso JA
    Rev Clin Esp; 1970 Feb; 116(3):217-28 contd. PubMed ID: 4913125
    [No Abstract]   [Full Text] [Related]  

  • 59. [HFE hemochromatosis: pathogenic and diagnostic approach].
    Brissot P; Le Lan C; Troadec MB; Lorho R; Ropert M; Lescoat G; Loréal O
    Transfus Clin Biol; 2005 Jun; 12(2):77-82. PubMed ID: 15925529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum transferrin receptor in hereditary hemochromatosis and African siderosis.
    Baynes RD; Cook JD; Bothwell TH; Friedman BM; Meyer TE
    Am J Hematol; 1994 Apr; 45(4):288-92. PubMed ID: 8178799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.